18
Aug
The escalating trade tensions between Washington and Brussels took a significant turn as former U.S. President Donald Trump agreed to withdraw plans for imposing an extraordinarily high tariff—reportedly 250 percent—on pharmaceutical imports from the European Union. This decision, which came as part of a broader trade arrangement, marks a critical moment in the long-standing negotiations between the two economic powerhouses and offers a temporary reprieve for industries on both sides of the Atlantic.The conflict originated during a time of escalating trade tensions when Washington aimed to address perceived ongoing disparities and unjust practices across industries like agriculture, technology, and healthcare.…
